What if cancer treatment could harness the body’s own immune system instead of relying on surgery, radiation, or chemotherapy? GT Biopharma (NASDAQ: GTBP) is developing its TriKE® platform, a novel NK cell engager designed to activate natural killer cells to seek out and destroy cancer.

In this interview, Executive Chairman & CEO Michael Breen discusses the company’s origins, the science behind its technology, and its progress in clinical trials for acute myeloid leukemia. He also outlines GT Biopharma’s plans to expand into solid tumors and autoimmune diseases, highlighting the commercial potential and challenges ahead.

Watch the full interview to learn how the company is advancing immunotherapy in a new direction.

Learn more about GT Biopharma: https://www.gtbiopharma.com/

Watch the full YouTube interview here: https://youtu.be/Z9tNa4JTELw
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Mining stocks are an untapped resource for long-term value. The question is: how do you maximize gold and silver stocks in your portfolio? Don Durrett, a gold and silver mining stock analyst at goldstockdata.com, shares his expert insights.

Fresh from this year’s Beaver Creek conference, Don Durrett discusses the companies that stood out, explains how economics can shift a miner’s trajectory, and highlights the key ‘checkboxes’ to look for before investing. He also breaks down the differences between producers, developers, and explorers and offers his macro view of today’s market.

Check out: https://www.goldstockdata.com

Watch the full YouTube interview here: https://youtu.be/9SFjtasYc6M
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Can ocean waves power the future? Eco Wave Power (NASDAQ: WAVE) believes the answer is yes.

In this interview, Founder & CEO Inna Braverman discusses the company’s historic launch of the first-ever onshore wave energy project in the U.S., located at the Port of Los Angeles. She also shares how they are expanding their international pipeline with projects in Israel, Portugal, Taiwan, India, and South Africa, while building strategic partnerships with industry giants like Shell, EDF Renewables IL, and Bharat Petroleum to accelerate commercialization.

With U.S. legislation now recognizing wave energy as a key part of the clean energy mix, Eco Wave Power is positioning wave power as a game-changing solution to meet rising demand from AI, electrification, and national security needs.

Learn more about Eco Wave Power: https://www.ecowavepower.com/

Watch the full YouTube interview here: https://youtu.be/rVhme5k3gDM
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

In this interview, Triumph Gold (TSXV: TIG | OTCMKTS: TIGCF | Frankfurt: 8N61) Principal Geologist Marty Henning shares updates on the Andalusite Peak Copper-Gold Project in British Columbia and the district-scale Freegold Mountain Project in Yukon.

He highlights promising copper, gold, and silver mineralization, outlines active exploration programs, and explains the strong infrastructure access that supports both projects. With exposure to critical metals and favorable market trends, Triumph Gold is positioned to benefit from rising copper demand and higher gold prices.

Learn more about Triumph Gold: https://triumphgoldcorp.com/

Watch the full YouTube interview here: https://youtu.be/tJMx6jT-WE0?si=XfmGJKGOYTbDD3BM
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

What if the next big investment frontier is humanoid robotics?

In this interview, Humanoid Global Holdings (CSE: ROBO | OTC: RBOHF | FRA: 0XM1) CEO Shahab Samimi and RideScan CEO Dr. Shivoh Chirayil Nandakumar discuss the future of robotics, safety, and why this sector is projected to reach $60 trillion.

They also explore how Humanoid Global Holdings is giving investors direct exposure to humanoid robotics through a diversified approach, and why partnering with RideScan’s safety platform is key to building trust, reducing risk, and opening doors in high-impact industries.

Discover how this partnership highlights the future of robotics and what it means for investors.

Learn more about Humanoid Global Holdings: https://www.humanoidglobal.ai
Discover RideScan: https://www.ridescan.ai/

Watch the full YouTube interview here: https://youtu.be/DF2nenmRbso?si=2qKn3TyDIMXT468Q
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Humanoid Global Holdings (CSE: ROBO | OTC: RBOHF | FRA: 0XM1) is helping shape the future of humanoid robotics and embodied AI.

In this interview, CEO Shahab Samimi shares how the company is positioning itself at the center of a fast-evolving industry. He talks about the forces driving robotics adoption, the role of software and data in shaping enterprise solutions, and how Humanoid Global is building a portfolio that looks beyond today’s market trends.

Tune in to learn about the vision and strategy behind one of the most forward-looking companies in the sector.

Learn more about Humanoid Global Holdings: https://www.humanoidglobal.ai

Watch the full YouTube interview here: https://youtu.be/txinZ_T9npI?si=YKQFqFWRRAWkMj3z
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Driven by defense spending and technology demand, tungsten is in a strong position in today’s market. American Tungsten (CSE: TUNG | OTCQB: TUNGF | FSE: RK9) is well-positioned to capture this opportunity through the IMA Mine Project in Idaho.

In this interview, CEO Ali Haji discusses why this is an exciting time for the company. He talks about how the company is preparing for drilling and for an updated resource statement aimed at extending the life of the mine, as well as strong financing updates.

Tune in to the full interview to learn how American Tungsten is advancing its strategy to secure a key role in the U.S. tungsten supply chain.

Explore: https://americantungstencorp.com/

Watch the full YouTube interview here: https://youtu.be/S5XoiYF3CkU
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Where should investors turn when markets get volatile?

Seasoned commodities and mining investor, and CEO of Feneck Consulting Group, John Feneck, shares his outlook on gold, silver, and other commodities. He explains why gold’s bull run has staying power, why silver still has massive upside, and how geopolitical events and Fed moves could shape the months ahead. Feneck also points to specific mining stocks he believes are undervalued and poised for growth.

Learn more about Feneck Consulting Group: https://www.feneckconsulting.com

Watch the full YouTube interview here: https://youtu.be/U--pPcI02Xw
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

With Sonora being the number one gold producer in Mexico, Sonoro Gold’s (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) flagship Cerro Caliche project represents a high-potential mineral asset.

President and CEO Kenneth MacLeod and Chairman John Darch provide an overview of the project, highlighting its location in a mining-friendly jurisdiction, the progress toward an updated PEA, and the advantages of its low initial capital requirements. They also discuss government support, advancements in permitting, and the key catalysts expected to shape the company’s trajectory over the next 12 to 18 months.

Watch the full interview to discover the project’s outlook and more.

Discover Sonoro Gold: https://sonorogold.com

Watch the full YouTube interview here: https://youtu.be/9KCeMSB7gMU
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

What if a drug could help chemotherapy patients continue treatment without painful side effects? Hoth Therapeutics (NASDAQ: HOTH) is making that possible by developing innovative treatments that address unmet medical needs and help patients maintain their therapy safely.

In this interview, CEO Robb Knie discusses HT001, the company’s lead drug currently in Phase 2 trials for chemotherapy-induced rash, and HTKIT, which shows promise in cancer treatment. He also shares how the company is advancing programs for Alzheimer’s and obesity, including an obesity drug licensed from the U.S. Department of Veterans Affairs.

With a diversified pipeline, a patient-focused approach, and strategic use of AI to de-risk and accelerate development, Hoth Therapeutics is positioning itself as a biotech company to watch.

Learn more about Hoth Therapeutics: https://hoththerapeutics.com

Watch the full YouTube interview here: https://youtu.be/AYQa3g6dVLA?si=w_zDH0TaSxP3m6Ji
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1